3-rx.comCustomer Support
3-rx.com
   
HomeAbout UsFAQContactHelp
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics



\"$alt_text\"');"); } else { echo"\"$alt_text\""; } ?>


Join our Mailing List





Syndicate

You are here : 3-RX.com > Home > Cancer -

Cord blood transplants a viable option in leukemia

CancerJun 16, 10

Adult patients with leukemia fare just as well when they get stem cell transplants taken from a cord blood bank as they do from a well-suited adult donor, U.S. researchers said on Tuesday.

They said umbilical cord transplants are a viable option for adults with leukemia who urgently need a bone marrow transplant to replace cells destroyed by chemotherapy or radiation treatments, but cannot find a donor.

“What we found is when you look at the outcome of leukemia-free survival, which is the likelihood of a patient being alive without disease, it’s the same whether you are transplanting using an adult graft which is from an adult donor or a cord blood unit,” said Dr. Mary Eapen of the Medical College of Wisconsin, whose study appears in the journal Lancet Oncology.

Cord blood worked even if it was not a great match, Eapen said in a telephone interview.

Only about half of all white adult patients can find a suitable donor, and the odds are much lower if the patient is African American or Asian, Eapen said.

“In general ... if you don’t have an acceptable tissue match with a donor, your chances of having a complication are higher and it can result in death,” she said.

But that is less so with stem cells from umbilical cord blood. “The body is more tolerant to the cells in the placental blood, even though they are not a perfect match.”

Eapen and colleagues analyzed data from 216 transplant centers worldwide. They compared the results of 165 patients 16 or older with acute leukemia who had been received umbilical cord blood to 888 adults given unrelated stem cell transplants, and 472 who had been given unrelated donor bone marrow.

After two years, all the patient groups were equally likely to survive and be free of leukemia regardless of graft source.

“The beauty of umbilical cord blood is you can use that for transplant patients who are not a perfect match and still come up with an acceptable endpoint, which is leukemia-free survival,” Eapen said.

She said most transplants being done with cord blood use public cord blood banks, in which parents have donated blood from their infant’s umbilical cord.

These have undergone strict testing to ensure the cells are safe and well preserved.

Private cord blood banks, such as those run by Cord Blood America Inc, typically collect and store cord blood for private use for an individual or family member, she said.

In an accompanying comment, Paul Szabolcs of Duke University Medical Center in Durham, North Carolina, said the analysis should bolster efforts to increase donations to public cord blood banks, particularly by minorities, who have the most trouble finding a matched donor.

Public cord blood banks cover the costs to collect, test and store umbilical cord blood.

SOURCE:  Lancet Oncology, online June 15, 2010.



Print Version
Tell-a-Friend
comments powered by Disqus

RELATED ARTICLES:
  New biomarkers may influence drug design and alternative treatments of cancer, study shows
  Metabolic profiles distinguish early stage ovarian cancer with unprecedented accuracy
  Moffitt researchers develop first genetic test to predict tumor sensitivity to radiation therapy
  New drug for neuroblastoma shows promise in phase I study
  Experimental treatment sends deadly leukemia into remission
  Study could reduce unnecessary cancer screening
  UA researchers discover component of cinnamon prevents colorectal cancer in mice
  Profiling approach to enable right lung cancer treatment match
  Fat grafting technique improves results of breast augmentation
  Germline TP53 mutations in patients with early-onset colorectal cancer
  Clinical trial suggests combination therapy is best for low-grade brain tumors
  UW research shows sensor technology may help improve accuracy of clinical breast exams

 












Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site